Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6417
-0.0204 (-3.08%)
At close: Feb 4, 2026, 4:00 PM EST
0.6289
-0.0128 (-1.99%)
After-hours: Feb 4, 2026, 7:57 PM EST

Werewolf Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
316614063328-
Market Cap Growth
-48.61%-52.79%121.66%-80.81%--
Enterprise Value
3-2062-62160-
Last Close Price
0.641.483.862.0511.91-
PS Ratio
-34.997.013.84--
PB Ratio
1.020.901.250.522.15-
P/TBV Ratio
1.050.901.250.522.15-
EV/Sales Ratio
--3.10---
Debt / Equity Ratio
1.260.510.470.120.100.03
Asset Turnover
-0.010.120.10--
Quick Ratio
3.737.317.005.6813.2717.52
Current Ratio
3.877.457.145.8413.5717.58
Return on Equity (ROE)
-122.43%-76.33%-31.98%-39.12%-41.31%-30.39%
Return on Assets (ROA)
-40.75%-30.48%-15.11%-20.64%-22.71%-23.72%
Return on Capital Employed (ROCE)
-115.50%-65.90%-26.10%-41.10%-29.90%-24.60%
Earnings Yield
-233.85%-106.92%-26.75%-85.38%-15.22%-
FCF Yield
-204.32%-85.58%-23.89%-70.14%-13.21%-
Buyback Yield / Dilution
-8.88%-23.04%-23.50%-56.40%-1736.32%-57.27%
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q